CFDA: Draft guidance? [RSABE / ABEL]

posted by libaiyi – China, 2018-06-13 03:39 (1192 d 21:13 ago) – Posting: # 18895
Views: 4,848

Thanks for you reply.

Another question,
how to write the null hypothesis and alternative hypothesis for BE based on FDA or EMA method?

Complete thread:

Activity
 Admin contact
21,689 posts in 4,534 threads, 1,541 registered users;
online 12 (0 registered, 12 guests [including 6 identified bots]).
Forum time: Saturday 00:52 CEST (Europe/Vienna)

Old beliefs die hard
even when demonstrably false.    E. O. Wilson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5